These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17666461)

  • 1. Effectiveness of a self-management intervention in patients with screen-detected type 2 diabetes.
    Thoolen B; De Ridder D; Bensing J; Maas C; Griffin S; Gorter K; Rutten G
    Diabetes Care; 2007 Nov; 30(11):2832-7. PubMed ID: 17666461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5-year and longer-term modelled outcomes of the ADDITION-Leicester study.
    Webb D; Dales J; Zaccardi F; Hill S; Moore C; Farooqi A; Griffin S; Davies M; Khunti K
    Diabetes Metab Res Rev; 2019 Mar; 35(3):e3111. PubMed ID: 30521699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Br J Gen Pract; 2009 Jan; 59(558):43-8. PubMed ID: 19105915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial.
    Webb DR; Khunti K; Gray LJ; Srinivasan BT; Farooqi A; Wareham N; Griffin SC; Davies MJ;
    Diabet Med; 2012 Apr; 29(4):531-40. PubMed ID: 21913966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.
    Simmons RK; Borch-Johnsen K; Lauritzen T; Rutten GE; Sandbæk A; van den Donk M; Black JA; Tao L; Wilson EC; Davies MJ; Khunti K; Sharp SJ; Wareham NJ; Griffin SJ
    Health Technol Assess; 2016 Aug; 20(64):1-86. PubMed ID: 27583404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus.
    Salinero-Fort MA; Carrillo-de Santa Pau E; Arrieta-Blanco FJ; Abanades-Herranz JC; Martín-Madrazo C; Rodés-Soldevila B; de Burgos-Lunar C
    BMC Public Health; 2011 Apr; 11():267. PubMed ID: 21524316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
    Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
    Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of clinical arterial pressure, home-arterial pressure measurement, and ambulatory arterial pressure monitoring in patients with type II diabetes mellitus and diabetic nephropathy].
    Lou LM; Gimeno JA; Gómez Sánchez R; Labrador T; Beguer P; Lou MT; Boned B; Aguilar E
    Nefrologia; 2002; 22(2):179-89. PubMed ID: 12085419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting.
    Brixner DI; McAdam-Marx C; Ye X; Boye KS; Nielsen LL; Wintle M; Misurski D; Fabunmi R
    Diabetes Obes Metab; 2009 Dec; 11(12):1122-30. PubMed ID: 19930004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysiologic outcomes of the Enhancing Adherence in Type 2 Diabetes (ENHANCE) trial.
    Sevick MA; Korytkowski M; Stone RA; Piraino B; Ren D; Sereika S; Wang Y; Steenkiste A; Burke LE
    J Acad Nutr Diet; 2012 Aug; 112(8):1147-57. PubMed ID: 22818724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.
    Margolis KL; O'Connor PJ; Morgan TM; Buse JB; Cohen RM; Cushman WC; Cutler JA; Evans GW; Gerstein HC; Grimm RH; Lipkin EW; Narayan KM; Riddle MC; Sood A; Goff DC
    Diabetes Care; 2014 Jun; 37(6):1721-8. PubMed ID: 24595629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nurse-led diabetes self-management education on glycosylated hemoglobin and cardiovascular risk factors: a meta-analysis.
    Tshiananga JK; Kocher S; Weber C; Erny-Albrecht K; Berndt K; Neeser K
    Diabetes Educ; 2012; 38(1):108-23. PubMed ID: 22116473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey.
    Charpentier G; Genès N; Vaur L; Amar J; Clerson P; Cambou JP; Guéret P;
    Diabetes Metab; 2003 Apr; 29(2 Pt 1):152-8. PubMed ID: 12746636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
    Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
    J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of treatment response in patients with newly diagnosed type 2 diabetes: the Skaraborg diabetes register.
    Pikkemaat M; Melander O; Hjerpe P; Bengtsson Boström K
    J Diabetes Complications; 2017 May; 31(5):854-858. PubMed ID: 28319005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist-led group medical appointment model in type 2 diabetes.
    Taveira TH; Friedmann PD; Cohen LB; Dooley AG; Khatana SA; Pirraglia PA; Wu WC
    Diabetes Educ; 2010; 36(1):109-17. PubMed ID: 19966072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes.
    Rothman RL; Malone R; Bryant B; Shintani AK; Crigler B; Dewalt DA; Dittus RS; Weinberger M; Pignone MP
    Am J Med; 2005 Mar; 118(3):276-84. PubMed ID: 15745726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.